Immune-mediated pachymeningitis (Q90287): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed label, description and/or aliases in pt-br, en |
Changed an Item |
||
| Property / Canonical URI | |||
| Property / Canonical URI: https://id.who.int/icd/entity/1948607488 / rank | |||
Normal rank | |||
Revision as of 17:14, 15 August 2026
Hypertrophic pachymeningitis due to an immune-mediated process. The syndrome is characterised by localised or diffuse thickening of the dura mater, although all three membranes may be involved. The cranial dura, spinal dura or both may be involved. The clinical features reflect the part of the neuraxis affected and may include headache, cranial nerve palsies, ataxia, paraparesis, sensory loss and loss of sphincter control. Diagnosis may be confirmed by neuroimaging, spinal fluid analysis and meningeal biopsy.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1948607488 |
||
| English | Immune-mediated pachymeningitis |
Hypertrophic pachymeningitis due to an immune-mediated process. The syndrome is characterised by localised or diffuse thickening of the dura mater, although all three membranes may be involved. The cranial dura, spinal dura or both may be involved. The clinical features reflect the part of the neuraxis affected and may include headache, cranial nerve palsies, ataxia, paraparesis, sensory loss and loss of sphincter control. Diagnosis may be confirmed by neuroimaging, spinal fluid analysis and meningeal biopsy. |
